Peter Attia· MD
human cancers are frequently dumping millions of cells into the blood and aesthetic sites metastasis are are relatively rare
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
human cancers are frequently dumping millions of cells into the blood and aesthetic sites metastasis are are relatively rare
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
but I think this is again is that small population dynamics that we we've talked about there's stochastic effects Al effects you know there's there's a lot of uh statistical uh problems with with going from a single cell to uh to to a cancer that's that's significant we are very lucky for that because we know that human cancers are frequently dumping Millions ions of cells into the blood and that metastatic sites met metastases are are are relatively rare
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.